Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.
about
Vaccinations for pregnant womenAcute respiratory failure in pregnancyChemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant ratsReview on the impact of pregnancy and obesity on influenza virus infectionInfectious respiratory disease outbreaks and pregnancy: occupational health and safety concerns of Canadian nurses.[Factors related to death by the Pandemic Influenza A (H1N1) 2009 in patients treated with oseltamivir].Impact on pregnancies in south Brazil from the influenza A (H1N1) pandemic: cohort study.H1N1 infection in Pregnancy: clinical course in two women.Risk management of seasonal influenza during pregnancy: current perspectives.Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo.2009 H1N1 influenza.Influenza and its treatment during pregnancy: A review.Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.Safety profile of oseltamivir during the 2009 influenza pandemic.Understanding the Influenza A H1N1 2009 PandemicMaternal deaths associated with H1N1 influenza virus infection in Turkey: a whole-of-population report.Optimizing knowledge of antiviral medications for prophylaxis and treatment of influenza during pregnancy.Perinatal outcomes and congenital abnormalities in the newborns of women affected by the 2009 pandemic influenza A (H1N1) in Beijing, China.Pandemic influenza A(H1N1) 2009 virus in pregnancy.Review of the pandemic (H1N1) 2009 among pregnant Japanese women.Prevention of novel influenza infection in newborns in hospital settings: considerations and strategies during the 2009 H1N1 pandemic.Influenza in pregnancy.Clinical use of approved influenza antivirals: therapy and prophylaxis.The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013Pregnancy outcomes of women exposed to laninamivir during pregnancy.Novel Influenza A (H1N1) Viral Infection in Late Pregnancy: Report of a CasePharmacokinetics of oseltamivir among pregnant and nonpregnant women.Human teratogens update 2011: can we ensure safety during pregnancy?Pregnancy with severe influenza A (H1N1) related acute respiratory distress syndrome: Report of three cases from a rural critical care unit in IndiaOseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.Swine flu and pregnancy.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Clinical focus: infections in pregnancy.Oseltamivir for influenza in pregnancy.Optimizing antiviral therapy for influenza: understanding the evidence.Oseltamivir for the treatment of H1N1 influenza during pregnancy.Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.The management of the critically ill obstetric patient.Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
P2860
Q26860740-A70DFD0C-EFF8-4D38-95E5-9D953BAFC9C9Q28077265-A58710F5-E043-442C-B9D7-BB657C1731B6Q28484222-7559BE69-905A-4FDE-A606-8D72E625EA5FQ30224744-6EA00B83-2F0A-430C-B5EF-BBAFFF197EFEQ30226417-D88A2232-B790-4948-8254-47A4B8707575Q30355484-08F736C1-D020-48D0-B62D-26DDF9E75559Q30359307-3704C54E-0C92-408B-9D3C-686E9936A535Q30359751-AED46D4A-6C50-44D7-A86B-93CC52F8E2C4Q30365596-997E528B-5D11-46E4-8086-BEEC1053E9D6Q30381783-475C8624-359C-4C7C-B38C-D2EC3BF0A668Q30383437-838485A4-3C0B-4081-97C2-1854E1A60838Q30384118-8DFA5330-DF00-461C-8CD2-D16C949F6022Q30388312-FE14D7D6-0452-46E8-A771-9AA012FB9C8EQ30391483-54D8A52D-BDD9-45FF-AFD0-3FB79755809BQ30401279-A00C4372-A097-43FF-89DD-364C0C62028BQ30402060-7193ED01-A63B-405A-8005-30A1845233E0Q30402747-7DEA229F-B6F4-43B9-95A7-EC5421B63D0BQ30406272-62B50DA4-06A0-4960-ACD5-E5DABC96E244Q30409603-5EF20562-2F6A-472F-BD3D-47C54DBD7D3BQ30414197-6A25B08B-3915-4E7B-8C5E-77319A55AC1DQ30415160-FE1AFB20-2C32-47E5-9A95-DC990151E6E5Q30418041-020787DA-C2A2-4714-B1E6-BE9BD1FB75BEQ30423910-C8C8E262-FA78-46A6-B663-2898C0AAF749Q30425343-A4EB4FEE-4081-4ED4-A3D7-652DC33418CBQ34389114-4F298469-6B74-4868-9E68-B2FB99D11FBAQ34693369-DAF1930F-1BF1-4DCE-A1D8-14C1C8C5A6A3Q34986168-6F6704D7-5C4B-428D-AA4C-E875D18AF6DEQ35036389-9246591B-45F4-4B09-B372-F8D09A640BD3Q35815011-FE32946C-E2B8-45A1-AFDC-FD177E9EF4C9Q36457985-AC6C11A0-5F3B-42FC-9559-18776F41D365Q36593645-A3F4CF38-ED6B-4363-8795-F279263726C2Q37689728-B3F7FEE5-DDBA-4FD7-B95C-167B8A8FDB63Q38084212-A86C61D0-633B-4600-8082-8A0D8794287AQ38207464-DC3D3479-0F5A-4B02-A4F0-14BA2E4A4490Q38256591-272AA999-F1EA-41C8-8516-13C6CF3183D3Q38361244-D77378A1-D48C-402A-812C-1BF2BFC37960Q38537284-6AB4090A-4E19-4B8D-8CCD-0B2A4EBB23FAQ41929666-FE93EFA3-764B-4D87-954A-A7145862E9C0Q46326866-52E7DB29-4F64-4FA4-B0A1-3699A9452919Q47837392-56606CD4-C46B-4FB1-A756-30F9289AEC79
P2860
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of neuraminidase inhibi ...... gnant and breastfeeding women.
@en
Safety of neuraminidase inhibitors against novel influenza A
@nl
type
label
Safety of neuraminidase inhibi ...... gnant and breastfeeding women.
@en
Safety of neuraminidase inhibitors against novel influenza A
@nl
prefLabel
Safety of neuraminidase inhibi ...... gnant and breastfeeding women.
@en
Safety of neuraminidase inhibitors against novel influenza A
@nl
P2093
P2860
P356
P1476
Safety of neuraminidase inhibi ...... gnant and breastfeeding women.
@en
P2093
Atsuko Murashima
Gideon Koren
Ken Nakajima
Shinya Ito
Toshihiro Tanaka
P2860
P356
10.1503/CMAJ.090866
P407
P577
2009-06-15T00:00:00Z